Effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis

Effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis

We investigated the effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis for 3 and 5 years. Significant improvement found the decrease of the frequency of clinical exacerbations and delay the accumulation of physical disability during treatment period.

Detalles Bibliográficos
Autores principales: V. M. Alifirova, M. A. Titova, A. A. Vereschaka
Formato: Artículo
Lenguaje:English
Publicado: Siberian State Medical University (Tomsk) 2010-08-01
Colección:Бюллетень сибирской медицины
Materias:
рассеянный склероз
частота обострений
балл edss
Acceso en línea:https://bulletin.ssmu.ru/jour/article/view/1618

Ejemplares similares

Ejemplares similares